Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 7 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 3 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 7 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced...
Benzinga· 1 day agoJim Cramer, the host of CNBC’s “Mad Money,” has warned investors about the current state of the...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 3 days agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Northwest Arkansas...
Northwest Arkansas Democrat Gazette· 4 days agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 6 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Top 25 Stocks in the S&P 500 by Index Weight Right Now
Insider Monkey via Yahoo Finance· 7 days agoIn this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now. If...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 2 days agoLooking at individual holdings, West Pharmaceutical Services Inc (WST) accounts for about 1.73% of...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 7 days agoThe Flagship Pioneering success story is now testing its Merck & Co.-partnered treatment, mRNA-4157,...